Fessler Barri J
Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, Medical Education Building, Room 609, 1813 Sixth Avenue South, 35294, USA.
Best Pract Res Clin Rheumatol. 2002 Apr;16(2):281-91. doi: 10.1053/berh.2001.0226.
Infections are one of the leading causes of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Therapeutic, disease-related and genetic factors all contribute to a lupus patient's increased susceptibility to infections. Although bacterial pathogens are the most common cause of infections, a wide variety of pathogens have been reported. In high-risk populations, identification and treatment of chronic infections such as tuberculosis, hepatitis B or human immunodeficiency virus, are important prior to the institution of immunosuppression to prevent reactivation or exacerbation of the infection. Judicious use of corticosteroids and cytotoxic drugs is critical in limiting infectious complications. Vaccines against influenza and pneumococcus appear to be safe and immunogenic in SLE patients and their routine administration should be encouraged.
感染是系统性红斑狼疮(SLE)患者发病和死亡的主要原因之一。治疗因素、疾病相关因素和遗传因素均导致狼疮患者对感染的易感性增加。尽管细菌病原体是感染最常见的原因,但已有多种病原体被报道。在高危人群中,在开始免疫抑制治疗之前,识别和治疗慢性感染(如结核病、乙型肝炎或人类免疫缺陷病毒)对于预防感染的再激活或加重很重要。合理使用皮质类固醇和细胞毒性药物对于限制感染并发症至关重要。流感疫苗和肺炎球菌疫苗在SLE患者中似乎是安全且具有免疫原性的,应鼓励常规接种。